Beijing Succeeder Technology Inc
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and… Read more
Beijing Succeeder Technology Inc (688338) - Total Liabilities
Latest total liabilities as of September 2025: CN¥81.48 Million CNY
Based on the latest financial reports, Beijing Succeeder Technology Inc (688338) has total liabilities worth CN¥81.48 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Beijing Succeeder Technology Inc - Total Liabilities Trend (2016–2024)
This chart illustrates how Beijing Succeeder Technology Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Beijing Succeeder Technology Inc Competitors by Total Liabilities
The table below lists competitors of Beijing Succeeder Technology Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Langfang Development Co Ltd
SHG:600149
|
China | CN¥245.58 Million |
|
TSS, Inc. Common Stock
NASDAQ:TSSI
|
USA | $102.00 Million |
|
Sinomach General Machinery Science Technology Co Ltd
SHG:600444
|
China | CN¥760.72 Million |
|
Great Tree Pharmacy Co Ltd
TWO:6469
|
Taiwan | NT$9.76 Billion |
|
Artius II Acquisition Inc. Units
NASDAQ:AACBU
|
USA | $12.83 Million |
|
Momentum Group AB (publ)
ST:MMGR-B
|
Sweden | Skr1.58 Billion |
|
Assembly Biosciences Inc
NASDAQ:ASMB
|
USA | $57.30 Million |
|
X-FAB Silicon Foundries SE
PINK:XFABF
|
USA | $893.73 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Beijing Succeeder Technology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 17.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Succeeder Technology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Succeeder Technology Inc (2016–2024)
The table below shows the annual total liabilities of Beijing Succeeder Technology Inc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥102.46 Million | -3.35% |
| 2023-12-31 | CN¥106.01 Million | -1.34% |
| 2022-12-31 | CN¥107.44 Million | +70.87% |
| 2021-12-31 | CN¥62.88 Million | +38.77% |
| 2020-12-31 | CN¥45.31 Million | -12.86% |
| 2019-12-31 | CN¥52.00 Million | +9.97% |
| 2018-12-31 | CN¥47.28 Million | +9.91% |
| 2017-12-31 | CN¥43.02 Million | -15.43% |
| 2016-12-31 | CN¥50.87 Million | -- |